4//SEC Filing
Rosebraugh Curtis 4
Accession 0001493152-22-003210
CIK 0001716947other
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 3:19 PM ET
Size
5.7 KB
Accession
0001493152-22-003210
Insider Transaction Report
Form 4
Rosebraugh Curtis
Director
Transactions
- Award
Stock Option
2022-02-04+20,000→ 20,000 totalExercise: $3.13Exp: 2032-02-04→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]On February 4, 2022, Mr. Rosebraugh was granted an option (the "Stock Option") to purchase 20,000 shares of common stock of Ensysce Biosciences, Inc. (the "Company"), par value $0.01 per share, with an exercise price of $3.13, under the that certain Ensysce Biosciences, Inc. Amended and Restated 2021 Omnibus Incentive Plan. The Stock Option is scheduled to vest on the date of the Company's annual stockholder meeting in 2022.
Documents
Issuer
Ensysce Biosciences, Inc.
CIK 0001716947
Entity typeother
Related Parties
1- filerCIK 0001869847
Filing Metadata
- Form type
- 4
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 3:19 PM ET
- Size
- 5.7 KB